Skip to main content

ACR 2025 Tweet by Janet Pope

View on
What to use in future for active #Sjogren's #SjD
B cell depletion, signal attenuation
Ianalumab 2+ phase3 RCTs
Telitacept +RCT

Nipocalimab FcRn +Ph2
Dazodalibep CD40L +Ph2

+RCTs
HCQ+Lef
Rituximab
?BTKi

#ACR25 @ACRheum @RheumNow
abst#LB24, LB11
×